'Love for the deal' was evident when Daiichi termed the investigations by the US Foods and Drugs Administration (FDA) as just a "risk call" and did not spend enough time on evaluating the risk,......
Drug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo said on Wednesday Ranbaxy will market its parent company's products in Malaysia as part of their initiative to harness synergies between......